Delayed Prostate Cancer Therapy Washington DC

The evidence seems to contradict the assumption that living with untreated prostate cancer is nerve-wracking for most patients, according to Dr. Roderick van den Bergh, of Erasmus Medical Center in Rotterdam, and colleagues.

STE 400
(703) 280-5390
8503 Arlington Blvd
Fairfax, VA
Business
Fairfax Northern Virginia Hematology & Oncolo
Specialties
Oncology

Data Provided by:
Gary L Guria, MR
(202) 639-8904
1455 F St NW
Washington, DC
Specialties
Oncology (Cancer)
Gender
Male
Education
Graduation Year: 2007

Data Provided by:
Fitzroy W Dawkins, MD
(202) 865-6625
2041 Georgia Ave NW
Washington, DC
Specialties
Oncology (Cancer)
Gender
Male
Education
Graduation Year: 2007

Data Provided by:
Rodger Jeffery Winn, MD
(713) 840-6060
601 13th St NW Ste 500N
Washington, DC
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Jefferson Med Coll-Thos Jefferson Univ, Philadelphia Pa 19107
Graduation Year: 1963

Data Provided by:
Sohail Rana, MD
(202) 865-3028
2041 Georgia Avenue North West South,
Washington, DC
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: King Edward Med Coll, Univ Of Punjab, Lahore, Pakistan
Graduation Year: 1975

Data Provided by:
Nelson G Kalil, MD
(301) 774-6136
18111 Prince Philip Dr
Olney, MD
Business
Community Hematology Oncology Practicioners
Specialties
Oncology

Data Provided by:
Louis W Sullivan, MD MACP
200 Independence Ave SW Ste 615-F
Washington, DC
Specialties
Internal Medicine, Hematology-Oncology
Gender
Male
Education
Medical School: Boston Univ Sch Of Med, Boston Ma 02118
Graduation Year: 1958

Data Provided by:
John Joseph Mc Grath, MD
1616 18th St NW
Washington, DC
Specialties
Oncology (Cancer), Radiation Oncology, Internal Medicine
Gender
Male
Education
Medical School: Univ Of Vt Coll Of Med, Burlington Vt 05405
Graduation Year: 1993

Data Provided by:
Fran Visc, MD
(202) 296-7477
1707 L St NW Ste 1060
Washington, DC
Specialties
Oncology (Cancer)
Gender
Male
Education
Graduation Year: 2007

Data Provided by:
Onyinye C Onyekwere, MD
(617) 355-6350
2041 Georgia Ave NW
Washington, DC
Specialties
Oncology (Cancer)
Gender
Female
Education
Medical School: Mi State Univ Coll Of Human Med, East Lansing Mi 48824
Graduation Year: 1995

Data Provided by:
Data Provided by:

Delayed Prostate Cancer Therapy

Provided By:

MONDAY, July 27 (HealthDay News) -- Men who delay treatment for their early prostate cancer are not especially anxious about living with the disease, new Dutch research shows.

The evidence seems to contradict the assumption that living with untreated prostate cancer is nerve-wracking for most patients, according to Dr. Roderick van den Bergh, of Erasmus Medical Center in Rotterdam, and colleagues. The findings are published in the Sept. 1 issue of Cancer.

The researchers surveyed 129 men regarding their levels of depression and anxiety over their treatment decision. More than 80 percent scored favorably low and compared well emotionally with patients who had opted for more aggressive treatment, the study found.

Men who were in poor general health and those with neurotic personalities expressed higher levels of anxiety and distress, suggesting that factors other than cancer may impact a patient's emotional response, the researchers noted.

The study is especially useful in an era when prostate-specific antigen tests and other screening exams are uncovering prostate cancer at increasingly earlier stages. Many physicians practice a "wait-and-see" approach to treatment, saving the more aggressive therapies for when the cancer grows or spreads, according to information in a news release from the American Cancer Society.

Nationally, prostate cancer is one of the most common cancers and is expected to strike more than 190,000 men this year, and result in over 27,000 deaths, according to the American Cancer Society. But thanks to more effective screenings and treatments, while one in six U.S. men will develop prostate cancer during their lifetime, only one in 35 will actually die of the disease. What's more, there are more than 2 million men in the United States who have been diagnosed with prostate cancer at some point and are still alive today, according to the society.

More information

The U.S. National Cancer Institute has more on prostate cancer.

SOURCE: American Cancer Society, news release, July 27, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com